The Present and Future of the Adult Pneumococcal Vaccine Program in the United States
AUTHORS
Kobayashi
M ,
Cohen
AL ,
Poehling
KA ,
. NEJM evidence. 2023 10 24; 2(11). EVIDra2300221
- PMID: 38320530 [PubMed].
ABSTRACT
Adult Pneumococcal Vaccine Program in the United States (pneumococcus) is a common cause of bacterial respiratory infections leading to substantial morbidity and mortality. Here, Kobayashi et al. discuss the recently updated U.S. guidelines for adult pneumococcal vaccination.
Tags: 2023 Alumni Publications